CF PharmTech was founded in Wuxi, Jiangsu province in 2008.
Through rapid growth, it becomes a fully integrated specialty pharmaceutical company dedicated to providing high-quality respiratory drugs for the global market.
Managed by a high-caliber team with extensive experience in the industry, the company focuses on the development of drugs for the treatment of respiratory diseases in its state-of-the-art facilities.
Our mission is to develop high-quality and affordable products to treat respiratory diseases and help patients to breathe easier and live better.
CF PharmTech was founded under Wuxi "530” Sponsorship Program
Received Jiangsu Provincial Innovation Award, and Science and Technology Leader Team Award
Secured a A-series capital investment, signed strategic partnership deal with Beijing SL Pharmaceutical
Wholly-owned subsidiary-Jiangsu CF PharmTech was set up in Wuxi; Filed 5 patents in China
Secured a B-series capital investment, startup Suzhou CF PharmTech
Completed the construction of Suzhou CF PharmTech
Secured a C-series capital investment, established the nasal spray and DPI production line
Secured a D-series capital investment of USD65 million
Secured a E-series capital investment of USD94 million
Secured a F-series capital investment of USD50 million
Budesonide Suspension for Inhalation and Salbutamol Sulfate inhalation solution were approved for market.